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Abstract 
 
Purpose: Dyssynchrony from biventricular pacing (BiV) can reduce dynamic obstruction in 
hypertrophic obstructive cardiomyopathy (HOCM), but its consequences on the left ventricular (LV) 
systolic function are unknown. We evaluate changes in LV systolic function and assess the effectiveness 
of BiV in HOCM. 
Methods: 13 patients with HOCM (55[33/75] years, 5 males) received a BiV device and 
underwent 2D transthoracic echocardiography before the implantation and at 12 months follow-up. 
Global longitudinal and radial strain, and the timing of segmental displacement curves were measured by 
commercial speckle-tracking software to assess LV systolic function and dyssynchrony. 
Results: Peak gradient in the LV outflow tract (LVOT) significantly decreased from 80[51/100] to 
30[5/66] mmHg (p=0.005). LV global strain was preserved from baseline to follow-up: 35.1[20.2/43.8]% 
vs. 32.6[27.1/44.1]%, p=NS (radial), and -16.6[-19.1/-14.4]% vs. -15.7[-17.0/-14.2]%, p=NS 
(longitudinal). Dyssynchrony analysis using displacement curves showed inversion of wall motion timing 
with earlier displacement of the lateral wall at follow-up only in patients with reduction in LVOT 
gradient.   
Conclusions: BiV reduces LVOT obstruction in patients with HOCM when dyssynchronization of 
LV motion and inversion of the timing of LV wall activation are reached. Notably, this does not lead to 
further deterioration of LV systolic function at mid-term follow-up. 
 
 
Keywords 
Speckle-tracking; Myocardial strain; Biventricular pacing; Hypertrophic obstructive cardiomyopathy. 
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Abbreviations 
 
AV: atrio-ventricular 
BiV: Biventricular pacing 
HOCM: Hypertrophic obstructive cardiomyopathy 
LV: Left ventricle 
LVOT: Left ventricle outflow tract 
RV: Right ventricle 
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Introduction 
 
Sixty percent of patients with hypertrophic cardiomyopathy have significant (≥30 mmHg) left 
ventricular outflow tract (LVOT) obstruction, either at rest or after provocation (e.g. a Valsalva 
maneuver), which contributes to symptoms and increases the risk of sudden cardiac death [1]. Dual-
chamber pacing is an alternative to surgical therapy or alcohol septal ablation [1]. 
 
However, controversial results for dual-chamber pacing efficacy [2] led to the research of 
alternative modes of pacing. Moreover, recent long-term follow-up data has raised concerns about 
chronic dual-chamber pacing in HOCM patients and a possible deleterious effect on survival and heart 
failure [3]. In accordance with this finding, some studies suggested that right ventricular (RV) pacing 
deteriorates left ventricular function in patients with HOCM both acutely and on the long-term run [4-6]. 
Similarly, studies in the population with normal or reduced ventricular function and without hypertrophic 
cardiomyopathy have showed an association between RV-pacing and the deterioration of left ventricle 
(LV) ejection fraction and the augmentation of the risk of hospitalization for heart failure [7-12].  
 
As an alternative, biventricular pacing (BiV) to reduce dynamic obstruction in hypertrophic 
obstructive cardiomyopathy (HOCM) has yielded encouraging results for reducing intraventricular 
obstruction and for clinical improvement [13-21]. However, while its effectiveness was demonstrated, the 
long-term effect of BiV-pacing on LV function among patients with HOCM and preserved LV ejection 
fraction is unknown. !!
The main contribution of this study consists in investigating the consequences of BiV on LV 
deformation, to determine whether the benefits of pacing-induced dyssynchrony are not hindered by 
lower LV systolic function. We previously reported on the effects of BiV in terms of LVOT pressure 
gradient and LV motion on 9 patients with HOCM [13]. The present study extends this work by a more 
comprehensive assessment of LV systolic function with deformation imaging at mid-term follow-up. 
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Methods 
 
Patients 
Between November 2005 and January 2013, 18 consecutive HOCM patients with significant 
LVOT obstruction (baseline intraventricular gradient 50 mmHg), LV ejection fraction ≥50%, sinus 
rhythm and severe symptoms despite optimum medical treatment and without indication for pacing due to 
bradycardia, were referred for BiV. Patients were accepted in the study only if surgical myomectomy or 
septal ablation were contraindicated (due to severe renal insufficiency, chronic obstructive pulmonary 
disease, liver cirrhosis) or were refused by the patient. Our institution’s Ethics committee approved the 
study protocol, and written informed consent was obtained from all patients. Patients were defined as 
responders to BiV if they completed both of the following criteria for reduction of obstructive gradient: 
(i) follow-up gradient ≤50 mmHg and (ii) reduction in LVOT pressure gradient of at least 50% from 
baseline. 
 
Cardiac resynchronization therapy device implantation 
The technique for device implantation has been described in detail elsewhere [13]. In brief, right 
leads were positioned conventionally in the right atrial appendage and RV apex. The LV lead was 
inserted via the coronary sinus and subsequently inserted in a ventricular vein and positioned as laterally 
as possible on the LV free-wall. All leads were connected to a dual-chamber biventricular implantable 
device and patients considered being at high risk for sudden cardiac death also received a cardioverter-
defibrillator.  
 
Echocardiographic evaluation 
All patients underwent standard transthoracic two-dimensional echocardiography before 
implantation, one day after implantation (for programming optimization) and follow-up. Parasternal and 
apical echocardiographic images were obtained with a commercially available system (Vivid7 and E9, 
GE Healthcare, Milwaukee, WI) using a 3.5-MHz transducer.  
 
LV wall thickness and diameters were measured from the parasternal long-axis view using M-
mode or 2D measurements at mitral valve leaflet tips level. LV mass was calculated using the Devereux 
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formula [22]. LV volumes and ejection fraction were obtained using the biplane Simpson method. The 
peak LVOT pressure gradient was determined using continuous wave Doppler from the apical five-
chamber view and was measured under resting conditions and after a provocative Valsalva maneuver. 
Values were determined by averaging measurements obtained in three consecutive cardiac cycles.  
 
Analysis of LV global radial and longitudinal strain was performed from the short-axis view at the 
papillary muscles level (average of 6 LV segments) and from 4-chamber apical (average of 6 LV 
segments) view, respectively, using commercial software (2D strain, Echopac, GE Healthcare). We have 
chosen to analyze GLS only in the 4-chamber as it allows visualizing the septum and the anterolateral 
wall in the same view, which is of interest to properly assess the changes induced by pacing. Besides, the 
reliable image quality of this view for strain quantification was also a criterion for privileging it while 
keeping measurements as simple as possible. The timing of displacement of opposing LV walls was 
assessed in the short-axis view at the papillary muscles level using displacement curves obtained by 
speckle-tracking. This view was chosen to explore the mechanisms gradient reduction as the dynamic 
obstruction predominates at this level. The sample of tissue interrogation was placed in the antero-septal 
and infero-lateral LV segments. In order to highlight the timing of wall motion, we measured the time-to-
onset of radial displacement (from beginning of QRS to beginning of wall displacement) and time-to-
peak of radial displacement (from beginning of QRS to peak systolic displacement). Comparison of 
timings between baseline and follow-up was made comparing infero-lateral to antero-septal (negative 
time value signifying that infero-lateral wall motion occurs first, and positive time value signifying that 
antero-septal displaces first).  
 
Optimization of the programming of the BiV device 
The algorithm for the optimization of the programming has been previously described elsewhere 
[13]. The optimum AV interval was considered as the shortest AV interval without A-wave truncation on 
the mitral inflow. Subsequently, ventricular pacing mode was selected testing RV-only pacing, LV-only 
pacing, or BiV-pacing with 4 different programs (RV preactivation VV+30ms, simultaneous BiV-pacing 
VV0ms, or LV preactivation VV-30ms, -60ms). The final pacing configuration was selected according to 
the maximum reduction of LVOT gradient after a 5 min equilibrium phase for each setup. The 
echocardiographer was blinded to pacing configuration. 
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Statistical analysis 
Due to the sample size of the study population, non-parametric test were used. Quantitative 
variables were expressed as median and first/third inter-quartile range while qualitative variables were 
described as number of cases (% from reference population). Paired dichotomous and quantitative 
variables were compared using Chi-square and Wilcoxon tests, respectively. A p-value <0.05 was 
considered statistically significant. 
 
Results 
 
Of the 18 patients, 1 did not complete the mid-term follow-up at the moment of analysis, and 4 
patients did not have images available for strain analysis, leaving a final cohort study of 13 patients with 
complete echocardiographic follow-up. Baseline characteristics are depicted in Table 1. Follow-up 
examination was performed at 12 months after implantation. Among the 13 patients in the study, 
optimum programming of the device based on maximum reduction in the LVOT gradient was VV+30 in 
1 patient (8%), VV0 in 3 patients (23%), VV-30 in 7 patients (54%), VV-60 in 1 patient (8%) and LV 
(activation of LV only) in 1 patient (8%).  
 
LVOT Obstruction 
Median peak LVOT gradient was 80[51/100] mmHg at baseline and significantly diminished after 
the activation of the resynchronization device to 45[20/60] mmHg and 30[5/66] mmHg at follow-up 
(p=0.005). Dynamic gradient with Valsalva maneuver was 110[78/130] mmHg before BiV and 
significantly diminished to 54[8/75] mmHg at follow-up (p=0.008). 
 
According to the reduction of LVOT obstruction, 8 (62%) patients were classified as responders 
and 5 (38%) patients as non-responders to BiV. Individual behaviors are shown in Figure 1.  
Intra- and inter-observer variability 
Repeatability in the extraction of myocardial motion, as conditioned by the speckle-tracking 
procedure, was previously reported [23]. These results are complemented by the measurements 
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summarized in Figure 2, which depict repeated curves along the whole cycle at basal septal/lateral levels 
and global values. Both indicate the low variability in the speckle-tracking measurements. 
 
Impact of BiV on LV function 
There was no significant change in the LV function according to ejection fraction estimated by the 
Simpson method. LV ejection fraction was 71[67/73] % at baseline and 69[65/75] % at follow-up 
(p=NS). Similarly, the LV systolic function as assessed by strain analysis did not significantly changed at 
follow-up. Global LV radial strain was 35.1[20.2/43.8] % at baseline and 32.6[27.2/44.1] % at follow-up 
(p=NS). Global longitudinal LV strain was -16.6[-19.1/-14.4] % at baseline and -15.70[-17.0/-14.2] % at 
follow-up (p=NS). (Table 2) Segmental LV strain analysis (radial and longitudinal) was not significantly 
different between baseline and follow-up, with the exception of the longitudinal strain of the septal-apical 
segment (-23.8[-34.3/-22.6] % to -21.9[-24.4/-19.0] %, p=0.009). (Figure 3) Finally, reductions in septal 
and posterior wall thickness were observed without significant changes in LV cavity size after BiV. 
(Table 1) This trend was mainly observed in patients who reduced LVOT gradient (responders) as shown 
in Table 2. 
 
Impact of BiV on LV dyssynchrony   
The changes in displacement of opposing LV walls from baseline to follow-up were significantly 
different between responders and non-responders to BiV (Table 3). In the responders, we observed a 
significant delay of the onset of antero-septal displacement (30[20/42] ms to 123[102/174] ms, p=0.028) 
combined with a non-significant delay of the onset of infero-lateral displacement (95[25/127] ms to 
127[103/138] ms) with BiV resulting in a significant (p=0.046) inversion in the timing of wall motion as 
compared to baseline: onset changing from antero-septal first to infero-lateral first.  
 
In the responders, we also observed a significant delay of the time to antero-septal peak 
displacement (363[320/407] ms to 542[481/577] ms) (p=0.028), combined with a non-significant delay of 
the time to infero-lateral peak displacement (421[358/515] ms to 418[367/455] ms) resulting in a 
significant (p=0.028) inversion in the timing of peak wall displacement as compared to baseline, 
changing from antero-septal wall first (infero-lateral 29[0/147] ms after antero-septal peak) to infero-
lateral wall peak first (infero-lateral -108[-186/-62] ms before antero-septal peak). 
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The inversion of the timing of wall displacement (onset and peak) was absent in the non-
responders. Representative examples of responder vs non-responder patients are illustrated in Figure 4.  
 
Discussion 
 
In this study on patients with HOCM at mid-term follow-up, we demonstrate that (i) BiV does not 
affect LV systolic function, and that (ii) LVOT obstruction is reduced when dyssynchronization of LV 
motion and inversion of the timing of LV wall activation are reached. This reduction of dynamic 
obstruction is associated with a change in the timings of the motion of opposing LV walls. 
 
Biventricular pacing in HOCM  
Current guidelines include cardiac pacing in HOCM as a class IIb indication and recommend dual-
chamber pacing in patients without bradycardia indication who are symptomatic despite optimum 
medical treatment and who are suboptimal candidates for invasive septal reduction (surgical or alcohol 
reduction) [1]. Although, the initials results for dual-chamber pacing were positive, Nishimura et al. 
showed in a randomized trial a weak reduction of LVOT gradient (<50%) and no improvement in 
exercise capacity on a short-term follow-up, suggesting a placebo effect for the observed symptomatic 
improvement [2]. More recently, BiV has shown to induce a significant gradient reduction from 74±23 
mmHg to 28±17 mmHg in 9 patients at 1-year follow-up in HOCM patients [13]. Lenarczyk et al. found 
similar results demonstrating significant reduction of peak gradient (60% reduction) in 9 patients with 
HOCM treated with BiV [15]. Similarly, smaller studies and case reports have shown the efficacy of BiV 
or LV-pacing for gradient reduction in the HOCM population [14,16-21]. Our results confirm a 
significant reduction of peak LVOT gradient at follow-up on a larger population (from 80[51/100] mmHg 
to 30[5/66] mmHg, p=0.005).  
 
Dyssynchronization as mechanism for LVOT obstruction relief 
The usual indication for BiV-pacing is for symptomatic patients with low LV ejection fraction (≤ 
35%) with QRS prolongation and is aimed at resynchronizing electromechanical activity of the heart with 
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the goal of improving ventricular function [24]. It is important to emphasize that the objective of BiV-
pacing in patients with HOCM is different, as it is indeed intended to dyssynchronize ventricular 
contraction and change the pattern of mechanical activation in order to reduce the dynamic obstruction. 
Using wall displacement traces (antero-septal and infero-lateral segments), we observed the inversion of 
the order of wall displacement, only in the responders, suggesting that the induced mechanical 
dyssynchrony plays a role in the reduction of LVOT obstruction.  
 
Impact of BiV-pacing on LV function 
In our population, we found a global LV longitudinal strain of -16.6[-19.1/-14.4]% and radial 
strain was 35.1[20.2/43.8]% at baseline, consistent with impaired LV myocardial deformation [25]. These 
findings are in keeping with previous reports describing reduced myocardial strain despite normal or 
supranormal LV ejection fraction in HOCM patients [26-28].  
 
Additionally, as shown in previous studies [26-29], regional septal longitudinal deformation is 
markedly reduced and this does not change after BIV-pacing. To our knowledge, the long-term effect of 
BiV-pacing on LV function in HCOM is unknown and our data are the first to reveal non-significant 
changes in LV radial and longitudinal strain or in LV ejection fraction. 
 
RV-pacing in HCOM 
From our results, the induced change in mechanical displacement of the LV free-wall, towards 
moving before the septum, is crucial for response. Therefore, the actual controversy about efficacy and 
placebo effect for RV-pacing in HOCM might be explained by the induction of a too small motion 
change of the interventricular septum, possibly due to the site of pacing being too close to the LV apex. 
By changing the timing of mechanical LV activation and inverting LV wall displacement, BiV might 
create changes in the 3-dimensional geometry of the LVOT and mitral valve apparatus resulting in the 
reduction of obstruction. As previously demonstrated [13], the acute reduction of gradient with BiV-
pacing supports this mechanical explanation for response and is corroborated by other short-term studies 
[15-17,19-21,30]. On a long-term basis, LV reverse remodeling might play an additional role as shown by 
significant reduction of septal and posterior wall thickness. Previous studies showed that in HOCM 
patients treated with RV-pacing, there was a gradient reduction during follow-up even when pacing was 
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turned off, suggesting a role of remodeling on the longer term [31]. 
 
Impact of RV-pacing on LV function 
LV dysfunction as a consequence of chronic RV-pacing is becoming an increasingly recognized 
entity in patients without HCM. In the PACE trial, deterioration of ejection fraction in the RV-pacing 
group was observed in comparison to no change of ejection fraction in CRT-pacing group [7,8]. The 
MOST study showed that cumulative percentage of pacing was a predictor for heart failure 
hospitalization [9,10]. Similarly, Tantengco et al. showed significant LV deterioration at long-term 
follow-up in 24 patients with congenital AV block in comparison to controls [11]. The DAVID study also 
showed that RV-pacing might be deleterious and increase heart failure events in some patients with 
ejection fraction ≤40% [32]. 
 
In hypertrophic cardiomyopathy, results are controversial. Lucon et al. reported the very long-term 
follow-up of 51 patients with HOCM treated with dual-chamber pacing and showed a non-significant 
reduction of ejection fraction (64% to 56%) [4]. Nishimura et al. and Betocchi et al. found LV diastolic 
and systolic deterioration during acute RV-pacing [5,6]. Moreover, recent long-term follow-up data in 
HOCM patients showed possible deleterious effect on survival and heart failure of RV-pacing in 
comparison to other management [3]. Conversely, others have showed no EF deterioration with dual-
chamber pacing [31,33]. 
 
While there is increasing evidence that RV-pacing deteriorates LV function in a lot of clinical 
settings, BiV-pacing has not been shown to induce the same effect and has rather been suggested as 
corrective therapy for RV-pacing induced LV dysfunction. This, together with our findings, suggests a 
benefit for preferring BiV-pacing in the HOCM population.  
 
Limitations 
The main limitation of this study is the small cohort of patients. Low study size might hinder the 
power of statistical comparisons and in particular the assessment of the lack of differences. Thus, our 
findings are preliminary data and have to be confirmed by larger studies. Nonetheless, it has to be noted 
that experience with BiV in HOCM patients is worldwide limited, and that our study presents a broader 
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population than previously published works. 
 
We are aware that choosing a definition for response to classify responders and non-responders is 
arbitrary but the criteria were chosen taking into consideration what might appear to be clinically 
relevant. A spectrum of response would be preferable but this was impossible considering the population 
size.  
 
We are also aware about the limitations of dyssynchrony measures especially when considered as 
predictors of outcome; however, it was not our principal objective, but rather an exploratory research for 
the mechanism of action. Moreover, inherent characteristics of HOCM (myocardial fiber disarray, 
markedly abnormal strain [34,35] and heterogeneous involvement of LV myocardial segment) pose a 
challenge for motion analysis. Potentially, more precise methods for the quantification of motion changes 
between baseline and follow-up may allow depicting more comprehensively these changes [23]. Besides, 
our analysis was only performed at rest. Its extension to stress conditions may be of added value, and 
should be considered for future studies. 
 
Conclusions 
 
Our results show that BiV reduces LVOT obstruction in patients with HOCM, by 
dyssynchronizing LV motion and inverting the timing of LV wall activation. Our study confirms that 
BiV-pacing is efficient in this task, as this does not lead to further deterioration of LV systolic function at 
mid-term follow-up. This is clinically reassuring and suggests a benefit for preferring BiV-pacing in the 
HOCM population. The confirmation of this finding would deserve further prospective larger studies. 
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Table 1. Baseline and follow-up characteristics of the studied population (N=13). Data are expressed 
as median (1st/3rd quartiles). 
 
 Baseline Follow-up p-value 
Sex (female,%) 8 (62%) NS 
Age (years) 55 (33/75) NS 
Rest LVOT gradient (mmHg) 80 (51/100) 30 (5/66) 0.005 
Provoked LVOT gradient (mmHg) 110 (78/130) 54 (8/75) 0.008 
NYHA class (patients,%) I - II 3 (23) 10 (77) p<0.005 
III-IV 10 (77) 3 (23) p<0.005 
Heart Rate (bpm) 67 (58/74) 62 (55/71) NS 
QRS duration (ms) 85 (79/102) 120 (113/125) 0.011 
E/A ratio 1.6 (0.9/1.9) 1.3 (0.6/1.5) p<0.005 
LVEDV (ml) 44 (35/49) 39 (35/49) NS 
LVESV (ml) 12 (10/17) 12 (9/16) NS 
LVEF (%) 71 (67/73) 69 (65/75) NS 
Short-axis radial strain (%) 35.1 (20.2/43.8) 32.6 (27.1/44.1) NS 
4-chamber longitudinal strain (%) -16.6 (-19.1/-14.4) -15.7 (-17.0/-14.2) NS 
Septal thickness (mm) 20 (18/27) 20 (16/26) 0.028 
Posterior wall thickness (mm) 12 (11/13) 11 (10/12) 0.016 
LV mass (g) 247 (203/363) 257 (171/364) NS 
LVEDV = Left ventricular end-diastolic volume, LVESV = Left ventricular end-systolic volume, LVOT = Left 
ventricular outfow tract. 
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Table 2: LV remodeling and systolic function with BiV in responders and non-responders. Data are 
expressed as median (1st/3rd quartiles). 
 
 Responders (n=8) Non-Responders (n=5) 
Baseline Follow-up Baseline Follow-up 
Rest LVOT gradient (mmHg) 96 (40/111) 15 (0/30)* 76 (64/83) 70 (55/88) 
Provoked LVOT gradient (mmHg) 111 (71/149) 33 (0/56)* 110 (85/120) 76 (72/120) 
Heart rate (bpm) 60 (56/72) 60 (52/71) 68 (63/82) 67 (59/74) 
LVEDV (ml) 45 (39/54) 40 (34/60) 44 (35/49) 39 (35/49) 
LVESV (ml) 12 (10/18) 13 (11/16) 12 (10/17) 12 (9/16) 
LVEF (%) 71 (67/74) 69 (65/75) 69 (63/72) 71 (55/74) 
LV radial strain (%) 31.4 
(22.9/48.1) 
32.1 
(25.4/40.2) 
37.3 
(14.5/43.5) 
35.5 
(23.8/55.9) 
LV longitudinal strain (%) -17.1 
(-20.0/-14.7) 
-15.6 
(-17.1/-14.7) 
-14.7 
(-17.8/-12.5) 
-13.8 
(-17.4/-11.7) 
Septal thickness (mm) 24 (19/28) 21 (18/26) 19 (17/27) 16 (15/26) 
LV Posterior wall thickness (mm) 12 (10/13) 11 (10/11)† 12 (12/14) 12 (11/14) 
LV mass (g) 358 (215/364) 268 (203/378) 239 (187/374) 227 (136/379) 
LVOT = Left ventricle outflow tract, LVEDV = Left ventricular end-diastolic volume, LVESV = Left ventricular end-
systolic volume, LVEF = Left ventricular ejection fraction; * p<0.02 (baseline vs. follow-up); † p<0.05 (baseline vs. follow-
up). 
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Table 3: Analysis of mechanical LV dyssynchrony with LV radial displacement in responders and non-
responders to BiV. 
 
 Responders (n=8) Non-Responders (n=5) 
Baseline Follow-up Baseline Follow-up 
T
im
e-
to
-o
ns
et
 o
f w
al
l 
di
sp
la
ce
m
en
t (
m
s)
 
∆ Time-to-onset (IL-AS) 74 
(-4/86) 
-16† 
(-60/31) 
0 
(0/15) 
-19 
(-71/-6) 
Septal Onset (ms) 30 
(20/42) 
123* 
(102/174) 
30 
(21/52) 
90† 
(58/118) 
Infero-Lateral Onset (ms) 95 
(25/127) 
127 
(103/138) 
30 
(21/67) 
45 
(28/84) 
T
im
e-
to
-P
ea
k 
w
al
l d
is
pl
ac
em
en
t 
(m
s)
 
∆ Time-to-peak (IL-AS) 29 
(0/147) 
-108* 
(-186/-62) 
0 
(-8/137) 
0 
(-177/37) 
Septal peak (ms) 363 
(320/407) 
542* 
(481/577) 
363 
(285/374) 
441 
(385/488) 
Infero-Lateral peak (ms) 421 
(358/515) 
418 
(367/455) 
368 
(364/422) 
374 
(287/479) 
AS: Anteroseptal, IL: infero-lateral; * p<0.03 (baseline vs. follow-up); † p<0.05 (baseline vs. follow-up). 
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Figures legend 
 
Figure 1: LVOT pressure gradient evolution 
 
Figure 2: Repeatability in the extraction of radial displacement and global longitudinal strain, as 
conditioned by the speckle-tracking procedure. Traces shown for the basal septal and lateral wall locations 
(radial displacement, left) and the whole myocardium (global longitudinal strain, right). Left: Intra-observer 
variability (single observer, single cycle, repeated 10 times). Middle: Inter-observer variability (2 different 
observers, single cycle). Right: Influence of the echocardiographic data (single observer, 3 consecutive cycles 
and 1 additional cycle from another sequence of the same patient [4-chamber view zoomed-in on the LV]) 
 
Figure 3: Global and segmental strain analysis: Baseline to Follow-up. Left: segmental and global radial 
peak systolic LV strain derived from the short-axis view at baseline (white) and follow-up (black). Right: 
segmental and global longitudinal peak systolic LV strain derived from the 4-chamber view at baseline (white) 
and follow-up (black). All non-significative changes from baseline to follow-up with exception of AS segment; 
*p=0.009; AS=Antero-septal, IS=Infero-septal, I=Inferior, IL=Infero-lateral, AL=Antero-lateral, A=Anterior. 
BS=Basal-septal, MS=Medio-Septal, ApS=Apical-septal, ApL=Apical-lateral, ML=Medio-lateral, BL=Basal-
lateral. 
 
Figure 4: Short-axis displacement curves: Specific behavior of a responder (top) versus a non-responder 
(bottom) patient from baseline (left) to follow-up (right) Top: Typical pattern of displacement from baseline to 
follow-up in a responder. (yellow curve: antero-septal, blue curve: infero-lateral). Observe the inversion and 
delay of septal onset of displacement (yellow arrow) and the inversion of peak displacement at follow-up. 
Bottom: Typical pattern of displacement from baseline to follow-up in a non-responder. (yellow curve: antero-
septal, blue curve: infero-lateral). Observe the absence of temporal inversion and delay of antero-septal onset of 
displacement (yellow arrow) and the absence of peak displacement inversion at follow-up. 
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Figure 1 
Baseline Follow-up
Pr
es
su
re
 g
ra
di
en
t (m
m
H
g)
Responders
Non-responders
0
20
40
60
80
100
120
 
Figure 2 
Single observer, single cycle, 10 times 2 di!erent observers, single cycle
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Figure 3 
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